{"id": "1367220382193889287", "creation": 1614805715.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 5, "quote_count": 0}}, "text": "Raymond James Analyst Thinks VBI Vaccines Stock Could Shoot Up by 170%\ud83e\udd14\n\n$VBI monovalent #Covid19 #vaccine is expected to enter Phase 1/2 trial this month after pre-clinical data showed the vaccine compared well against $NVAX\n\n$TBIO $VXRT $BVXV #stocks\n\nhttps://t.co/cMlCdsIBgP", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKS"]}